Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Precision Health Database


Genomics & Health Impact Scan Database|Search|PHGKB

Cancer

Last data update: Mar 21, 2023. (Total: 58828 Documents since 2012)
   dataset      
Filtered By:

Previous    

Records 1 - 29 (of 29 Records)

Query Trace: Melanoma[original query]>>Evidence Synthesis [Product Type]
Strategies to Improve Adherence to Skin Self-examination and Other Self-management Practices in People at High Risk of Melanoma: A Scoping Review of Randomized Clinical Trials.
Deonna M Ackermann et al. JAMA dermatology 2023
Cost-effectiveness of immune checkpoint inhibition and targeted treatment in combination as adjuvant treatment of patient with BRAF-mutant advanced melanoma.
Li Si Ni et al. BMC health services research 2023 23(1) 49
Distinguish the Value of the Benign Nevus and Melanomas Using Machine Learning: A Meta-Analysis and Systematic Review.
Li Suli et al. Mediators of inflammation 2022 20221734327
Artificial intelligence and machine learning algorithms for early detection of skin cancer in community and primary care settings: a systematic review.
Jones O T et al. The Lancet. Digital health 2022 4(6) e466-e476
Integrating Patient Data Into Skin Cancer Classification Using Convolutional Neural Networks: Systematic Review.
Höhn Julia et al. Journal of medical Internet research 2021 23(7) e20708
A Systematic Review on the Impact of Genetic Testing for Familial Melanoma II: Psychosocial Outcomes and Attitudes.
Primiero Clare A et al. Dermatology (Basel, Switzerland) 2021 Jan 1-11
Frontline BRAF Testing-Guided Treatment for Advanced Melanoma in the Era of Immunotherapies: A Cost-Utility Analysis Based on Long-term Survival Data.
Wu Bin et al. JAMA dermatology 2020 Jul
Performance of Gene Expression Profile Tests for Prognosis in Patients With Localized Cutaneous Melanoma A Systematic Review and Meta-analysis
MA Marchetti et al, JAMA Dermatology, July 29, 2020
Molecular risk prediction in cutaneous melanoma: a meta-analysis of the 31-gene expression profile prognostic test in 1,479 patients.
Greenhaw Bradley N et al. Journal of the American Academy of Dermatology 2020 Mar
Characterizing the Role of Dermatologists in Developing AI for Assessment of Skin Cancer: A Systematic Review.
Zakhem George A et al. Journal of the American Academy of Dermatology 2020 Jan
Benefits, harms and cost-effectiveness of cancer screening in Australia: an overview of modelling estimates.
Lew Jie-Bin et al. Public health research & practice 2019 Jul 29(2)
CLINGEN Actionability Report for Basal Cell Nevus Syndrome (BCNS) - PTCH1
ClinGen Actionability Working Group
CLINGEN Actionability Report for Tumor Predisposition Syndrome - BAP1
ClinGen Actionability Working Group
CLINGEN Actionability Report for Pancreatic cancer/melanoma syndrome - CDKN2A
ClinGen Actionability Working Group
CLINGEN Actionability Report for PTEN Hamartoma Tumor Syndrome - Cowden Syndrome-PTEN
ClinGen Actionability Working Group
CLINGEN Actionability Report for Retinoblastoma-RB1
ClinGen Actionability Working Group
CLINGEN Actionability Report for Birt-Hogg-Dub� syndrome - FLCN
ClinGen Actionability Working Group
Accuracy of Computer-Aided Diagnosis of Melanoma: A Meta-analysis.
Dick Vincent et al. JAMA dermatology 2019 Jun
Behavioral impact of return of genetic test results for complex disease: Systematic review and meta-analysis.
Frieser Maia J et al. Health psychology : official journal of the Division of Health Psychology, American Psychological Association 2018 Oct
Systematic Review and Meta-analysis of the Prognostic Significance of miRNAs in Melanoma Patients.
Sabarimurugan Shanthi et al. Molecular diagnosis & therapy 2018 Sep
Results of surveillance in individuals at high-risk of pancreatic cancer: A systematic review and meta-analysis.
Signoretti Marianna et al. United European gastroenterology journal 2018 May 6(4) 489-499
Molecular testing for BRAF mutations to inform melanoma treatment decisions: a move toward precision medicine.
Cheng Liang et al. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2017 Nov
Cost-Effectiveness of Immune Checkpoint Inhibition in BRAF Wild-Type Advanced Melanoma.
Kohn Christine G et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2017 Feb JCO2016696336
Validity of self-reported family history of cancer: A systematic literature review on selected cancers.
Fiederling Jonas et al. International journal of cancer 2016 May
Cost Effectiveness of Sequencing 34 Cancer-Associated Genes as an Aid for Treatment Selection in Patients with Metastatic Melanoma.
Li Yonghong et al. Molecular diagnosis & therapy 2015 Jun 19(3) 169-77
Efficacy and Safety of Nivolumab in Patients With BRAF V600 Mutant and BRAF Wild-Type Advanced Melanoma: A Pooled Analysis of 4 Clinical Trials.
Larkin James, et al. JAMA oncology 2015 7 0. (4) 433-40
Clinical practice guidelines for identification, screening and follow-up of individuals at high risk of primary cutaneous melanoma: a systematic review.
Cost-effectiveness of treatment strategies for BRAF-mutated metastatic melanoma.
A prognostic test to predict the risk of metastasis in uveal melanoma based on a 15-gene expression profile.
TOP